Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses is adult recipients of hematopoietic stem cell transplants for hematologic malignancies

Rodrigo Martino, Rocío Parody Porras, Nuria Rabella, John V. Williams, Elena Rámila, Nuria Margall, Rosa Labeaga, James E. Crowe, Pedro Coll, Jorge Sierra

Research output: Contribution to journalArticleResearchpeer-review

159 Citations (Scopus)

Abstract

Respiratory viruses (RVs) are known to be major causes of morbidity and mortality in recipients of hematopoietic stem cell transplants (HSCTs), but prospective long-term studies are lacking. We prospectively screened all adult HSCT recipients (172 allogeneic [alloHSCT] and 240 autologous [autoHSCT]) who underwent transplantation during a 4-year period (1999 to 2003) for the development of a first episode of symptomatic upper respiratory tract infections and/or lower respiratory tract infections (LRTI) by an RV. RVs studied were influenza A and B viruses (n = 39), human respiratory syncytial virus (n = 19), human adenoviruses (n = 11), human parainfluenza viruses 1 to 3 (n = 8), human enteroviruses (n = 5), human rhinoviruses (n = 3), and the recently discovered human metapneumoviruses (n = 19). During the study, 51 and 32 cases of RV symptomatic infections were identified of alloHSCT and autoHSCT recipients (2-year incidence, 29% and 14%, respectively). Risk factors for progression of upper respiratory tract infection to LRTI included severe (< 0.2 × 109/L) and moderate (< 0.2 × 109/L) lymphocytopenia in alloHSCT (P = .02) and autoHSCT (P = .03). Death from LRTI was attributed to an RV in 8 alloHSCT recipients. Symptomatic RV had no effect on 2-year outcomes, with the possible exception of influenza A and B virus infections in autoHSCT: these were associated with nonrelapse mortality (P = .02). In conclusion, this prospective trial allows an estimation of the minimum incidence of a first RV infection in adult HSCT recipients and identifies risk factors for acquisition of an RV infection and progression to LRTI; this should aid in the design of future studies. In addition, human metapneumovirus should be added to the potentially serious causes of RV infections in HSCT. © 2005 American Society for Blood and Marrow Transplantation.
Original languageEnglish
Pages (from-to)781-796
JournalBiology of Blood and Marrow Transplantation
Volume11
Issue number10
DOIs
Publication statusPublished - 1 Oct 2005

Keywords

  • Hematopoietic stem cell transplantation
  • Prospective study
  • Respiratory tract infection
  • Respiratory viruses

Fingerprint Dive into the research topics of 'Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses is adult recipients of hematopoietic stem cell transplants for hematologic malignancies'. Together they form a unique fingerprint.

Cite this